Paragon Bioservices Inc. infectious news

Contract research and manufacturing organization Paragon received a contract from the U.S. Department of Defense for the development and subsequent GMP manufacturing of a Venezuelan equine encephalitis (VEE) replicon particle trivalent filovirus vaccine. The company said the contract is initially worth about $15 million, though the value could double if certain options are exercised. Under the contract, Paragon will develop a large-scale mammalian process that is suitable for cGMP manufacturing. ...